Terms: = Colorectal cancer AND TFRC, P02786, 7037, ENSG00000072274, TFR1, CD71 AND Treatment
12 results:
1. Feasibility of implementation of the early tumor shrinkage as a potential predictive marker to daily clinical practice in patients with RAS wild type metastatic colorectal cancer, treated with cetuximab - a non-interventional observational study.
Fínek J; Vočka M; Bauer J; Kubala E; Zycháčková K; Šedivá M; Gharibyar M; Kocáková I; Čmuchařová E; Vaňková M
Klin Onkol; 2024; 38(2):110-117. PubMed ID: 38697819
[TBL] [Abstract] [Full Text] [Related]
2. β-Lapachone induces ferroptosis of colorectal cancer cells via NCOA4-mediated ferritinophagy by activating JNK pathway.
Zhao L; Miao H; Quan M; Wang S; Zhang Y; Zhou H; Zhang X; Lin Z; Piao J
Chem Biol Interact; 2024 Feb; 389():110866. PubMed ID: 38218311
[TBL] [Abstract] [Full Text] [Related]
3. Proteomics study of colorectal cancer and adenomatous polyps identifies tfr1, SAHH, and HV307 as potential biomarkers for screening.
Tang M; Zeng L; Zeng Z; Liu J; Yuan J; Wu D; Lu Y; Zi J; Ye M
J Proteomics; 2021 Jul; 243():104246. PubMed ID: 33915303
[TBL] [Abstract] [Full Text] [Related]
4. Radiotherapy and immunotherapy converge on elimination of tumor-promoting erythroid progenitor cells through adaptive immunity.
Hou Y; Liang HL; Yu X; Liu Z; Cao X; Rao E; Huang X; Wang L; Li L; Bugno J; Fu Y; Chmura SJ; Wu W; Luo SZ; Zheng W; Arina A; Jutzy J; McCall AR; Vokes EE; Pitroda SP; Fu YX; Weichselbaum RR
Sci Transl Med; 2021 Feb; 13(582):. PubMed ID: 33627484
[TBL] [Abstract] [Full Text] [Related]
5. High activity and low toxicity of a novel cd71-targeting nanotherapeutic named The-0504 on preclinical models of several human aggressive tumors.
Falvo E; Damiani V; Conti G; Boschi F; Messana K; Giacomini P; Milella M; De Laurenzi V; Morea V; Sala G; Fracasso G; Ceci P
J Exp Clin Cancer Res; 2021 Feb; 40(1):63. PubMed ID: 33568214
[TBL] [Abstract] [Full Text] [Related]
6. Protein Encapsulation of Experimental Anticancer Agents 5F 203 and Phortress: Towards Precision Drug Delivery.
Breen AF; Scurr D; Cassioli ML; Wells G; Thomas NR; Zhang J; Turyanska L; Bradshaw TD
Int J Nanomedicine; 2019; 14():9525-9534. PubMed ID: 31824148
[TBL] [Abstract] [Full Text] [Related]
7. Advancement of the study on iron metabolism and regulation in tumor cells.
Wang SJ; Gao C; Chen BA
Chin J Cancer; 2010 Apr; 29(4):451-5. PubMed ID: 20346225
[TBL] [Abstract] [Full Text] [Related]
8. Metabolic syndrome components and colorectal adenoma in the CLUE II cohort.
Tsilidis KK; Brancati FL; Pollak MN; Rifai N; Clipp SL; Hoffman-Bolton J; Helzlsouer KJ; Platz EA
Cancer Causes Control; 2010 Jan; 21(1):1-10. PubMed ID: 19774471
[TBL] [Abstract] [Full Text] [Related]
9. Starlike vs. classic macromolecular prodrugs: two different antibody-targeted HPMA copolymers of doxorubicin studied in vitro and in vivo as potential anticancer drugs.
Jelínková M; Strohalm J; Etrych T; Ulbrich K; Ríhová B
Pharm Res; 2003 Oct; 20(10):1558-64. PubMed ID: 14620507
[TBL] [Abstract] [Full Text] [Related]
10. Differences in the intracellular fate of free and polymer-bound doxorubicin.
Hovorka O; St'astný M; Etrych T; Subr V; Strohalm J; Ulbrich K; Ríhová B
J Control Release; 2002 Apr; 80(1-3):101-17. PubMed ID: 11943391
[TBL] [Abstract] [Full Text] [Related]
11. Site-specific expression of transferrin receptor by human colon cancer cells directly correlates with eradication by antitransferrin recombinant immunotoxin.
Shinohara H; Fan D; Ozawa S; Yano S; Van Arsdell M; Viner JL; Beers R; Pastan I; Fidler IJ
Int J Oncol; 2000 Oct; 17(4):643-51. PubMed ID: 10995873
[TBL] [Abstract] [Full Text] [Related]
12. A phase II study of advanced colorectal cancer patients treated with combination 5-fluorouracil plus leucovorin and subcutaneous interleukin-2 plus alpha interferon.
Ridolfi R; Maltoni R; Riccobon A; Flamini E; Fedriga R; Milandri C; Pezzi L; Velotti F; Santoni A; Amadori D
J Chemother; 1994 Aug; 6(4):265-71. PubMed ID: 7830105
[TBL] [Abstract] [Full Text] [Related]
